CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 21969131)

Published in World J Urol on October 04, 2011

Authors

Walter Henriques da Costa1, Rafael Malagoli Rocha, Isabela Werneck da Cunha, Francisco Paula da Fonseca, Gustavo Cardoso Guimaraes, Stenio de Cassio Zequi

Author Affiliations

1: Urology, A.C. Camargo Hospital, Rua Cerro Cora 1540, Alto de Pinheiros, Sao Paulo, SP, Brazil. waltercosta@hotmail.com

Articles cited by this

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47

Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst (2006) 6.58

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev (2008) 4.25

Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A (1997) 4.04

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95

CD133: molecule of the moment. J Pathol (2008) 3.58

Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol (2000) 3.27

Isolation of renal progenitor cells from adult human kidney. Am J Pathol (2005) 3.12

Renal mass biopsy--a renaissance? J Urol (2007) 3.12

HIF induces human embryonic stem cell markers in cancer cells. Cancer Res (2011) 2.46

Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst (1971) 2.17

The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res (2010) 2.12

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic (2001) 2.03

Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res (1986) 2.01

Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. J Urol (2007) 1.58

Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol (2009) 1.58

Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol (2005) 1.55

CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol (2006) 1.36

Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev (2009) 1.23

Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor. BJU Int (2007) 1.04

Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) (2008) 0.95

Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis. Bioessays (2007) 0.94

CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas. Pancreas (2009) 0.91

Distant metastasis of renal cell carcinoma with a diameter of 3 cm or less-which is aggressive cancer? J Urol (2010) 0.90

Prognostic stratification of localized renal cell carcinoma by tumor size. J Urol (2008) 0.88

Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers. World J Gastroenterol (2010) 0.88

Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification. J Urol (2008) 0.83

Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma. Int J Urol (2009) 0.79

Articles by these authors

GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma. Molecules (2010) 1.27

Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors. Transl Oncol (2010) 0.97

Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer. J Transl Med (2013) 0.92

Prognostication of OCT4 isoform expression in prostate cancer. Tumour Biol (2013) 0.90

Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma. Histopathology (2011) 0.89

Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance. Int Braz J Urol (2012) 0.87

MGMT and PTEN as potential prognostic markers in breast cancer. Exp Mol Pathol (2011) 0.85

Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology. Int Braz J Urol (2012) 0.85

An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas. PLoS One (2013) 0.82

Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast. Transl Oncol (2012) 0.82

Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside. J Transl Med (2012) 0.81

Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast. Clinics (Sao Paulo) (2013) 0.80

Penile cancer: epidemiology and treatment. Curr Oncol Rep (2011) 0.79

Glial fibrillary acidic protein in tumor types with cartilaginous differentiation. Mod Pathol (2009) 0.79

Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype. Urology (2013) 0.79

Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein. Ann Surg Oncol (2012) 0.79

False positivity in HER2 testing of breast cancer: novel paths for approaching an old dilemma. J Clin Pathol (2013) 0.79

Impact of renal vein invasion and fat invasion in pT3a renal cell carcinoma. BJU Int (2011) 0.79

Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin. Ann Surg Oncol (2011) 0.78

Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma. Virchows Arch (2014) 0.78

Morphological aspects and immunophenotypic profiles of mammary carcinomas in benign-mixed tumors of female dogs. Vet Med Int (2012) 0.78

microRNA portraits in human vulvar carcinoma. Cancer Prev Res (Phila) (2013) 0.77

EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study. BMJ Open (2013) 0.77

Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities. Eur J Cancer (2010) 0.76

Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma. Tumour Biol (2013) 0.76

Comment on: EGFR mutational status in Brazilian patients with penile carcinoma. Expert Opin Ther Targets (2013) 0.75

The role of interleukin-6, endothelins, and apoptotic genes in small bowel transplantation, in a swine model of ischemia and reperfusion injury. Pediatr Transplant (2011) 0.75

Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer? Ann Surg Oncol (2012) 0.75

Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence. Tumour Biol (2015) 0.75

Chromosomal imbalances exclusively detected in invasive front area are associated with poor outcome in laryngeal carcinomas from different anatomical sites. Tumour Biol (2013) 0.75

[Hemicorporectomy with double barreled wet colostomy: an extremely rare procedure]. Rev Col Bras Cir (2009) 0.75